aTYR PHARMA INC (ATYR) stock
ATYRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$4.99−0.25 (-4.77%)
Close on Nov 17, 2026Market cap $489.46MP/E –Yield –
aTYR PHARMA enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
aTYR PHARMA's enterprise value was -$41.01M on Nov 11, 2026, against -$8.86M a year earlier. Over the last 5 years it ranged from -$83.42M to $419.11M, with a median of -$2.42M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$41.01M | – |
| 2025 | Dec 31, 2025 | -$83.42M | -140.1% |
| 2024 | Dec 31, 2024 | $208.26M | – |
| 2023 | Dec 29, 2023 | -$19.75M | – |
| 2022 | Dec 30, 2022 | -$14.02M | -115.4% |
| 2021 | Dec 31, 2021 | $91.07M | +1550.7% |
| 2020 | Dec 31, 2020 | $5.52M | – |
| 2019 | Dec 31, 2019 | -$11.26M | – |
| 2018 | Dec 31, 2018 | -$23.22M | -181.9% |
| 2017 | Dec 29, 2017 | $28.37M | – |
| 2016 | Dec 30, 2016 | -$19.54M | -115.8% |
| 2015 | Dec 31, 2015 | $123.57M | – |
See a number that looks wrong?